Allero Therapeutics

Allero Therapeutics: a biopharmaceutical company developing next generation immunotherapies for immune mediated diseases


Allero Therapeutics

Problem & Solution

The Problem
Abnormal immune response can cause chronic and life threatening conditions. Current therapies are injection-based, do not reinstate tolerance, but instead treat symptoms or suppress immune system with potential side effects.

The Solution
An ideal therapeutic would restore normal immune balance/tolerance, avoid global immune suppression and treat the cause of the disease,
Based on research by the founders and their collaborators the team has identified a novel specific immunotherapy approach based on antigen-specific tolerance induction. The approach defines a platform technology which is broadly applicable to a range of clinical indications with profound unmet medical need, e.g. autoimmune and allergic diseases.

Thank you for registering to Bloomio

To activate your account please confirm your email address by clicking on the link we sent to your inbox.

Email not received?
Please check your spam folder or contact us at

We’re experiencing a problem here, our developers are on the case. Please try it later.

Please update your profile details in order to use Bloomio’s services. uses cookies and tracking to provide better user experience and functionality. By  continuing to browse this web-site you are agreeing to the use of cookies and tracking. More about cookies can be found here